Patient Blood Management and Its Role in Supporting Blood Supply

References

• US Department of Health and Human Services Report to Congress on the Adequacy of the National Blood Supply 2020; 2020. Available from: https://www.aabb.org/docs/default-source/default-document-library/positions/hhs-report-to-congress-on-The-adequacy-of-The-national-blood-supply.pdf?sfvrsn=aeea20ff_4. Accessed December 16, 2022.
   Google Scholar
• Mulcahy A, Kapinos K, Briscomb B, et al. Toward a Sustainable Blood Supply in the United States: An Analysis of the Current System and Alternatives for the Future. Rand Corporation; 2016.
   Google Scholar
• Cohn CS, Pagano MB, Allen ES, et al. How do I manage long‐term blood component shortages in a hospital transfusion service? Transfusion. 2020:trf.15857. doi:10.1111/trf.15857
   Google Scholar
• McCarthy LJ. How do I manage a blood shortage in a transfusion service? Transfusion. 2007;47(5):760–762. doi:10.1111/j.1537-2995.2007.01187.x
   PubMed Web of Science ®Google Scholar
• Mowla SJ, Sapiano MRP, Jones JM, Berger JJ, Basavaraju SV. Supplemental findings of the 2019 National Blood Collection and Utilization Survey. Transfusion. 2021;61(S2):S11–S35. doi:10.1111/trf.16606
   PubMedGoogle Scholar
• Shander A, Hardy JF, Ozawa S, et al. A Global definition of patient blood management. Anesth Analg. 2022;135(3):476–488. doi:10.1213/ANE.0000000000005873
   PubMed Web of Science ®Google Scholar
• Blanton K. What’s in a name: the role and impact of the Transfusion Safety Officer. In: AABB Annual Meeting Highlights Conference & Exposition in the Middle East; 2020.
   Google Scholar
• World Health Organization. Blood Donor Selection: Guidelines on Assessing Donor Suitability for Blood Donation. World Health Organization; 2012.
   Google Scholar
• World Health Organization. The urgent need to implement patient blood management: policy brief; 2021. Available from: https://apps.who.int/iris/bitstream/handle/10665/346655/9789240035744-eng.pdf. Accessed November 7, 2023.
   Google Scholar
• Nissen-Meyer LSH, Seghatchian J. Donor health assessment – when is blood donation safe? Transfus Apher Sci. 2019;58(1):113–116. doi:10.1016/j.transci.2018.12.016
   PubMed Web of Science ®Google Scholar
• Kessler D, Rossmann S. Allogeneic and autologous blood donor selection. In: Cohn C, Delaney M, Johnson S, Katz L, editors. Technical Manual. 20th ed. AABB Press; 2020.
   Google Scholar
• Association for the Advancement of Blood and Biotherapies. Individual risk assessment donor history questionnaire example model using Canada’s eligibility criteria; 2023. Availabe from: https://www.aabb.org/docs/default-source/default-document-library/resources/individual-risk-assessment-dhq-example-model-using-canadas-eligibility-criteria.pdf. Accessed May 19, 2023.
   Google Scholar
• US Food and Drug Administration. Implementation of Acceptable FullLength and Abbreviated Donor History Questionnaires and Accompanying Materials for Use in Screening Donors of Source Plasma; 2023.
   Google Scholar
• US Food and Drug Administration. Recommendations for Evaluating Donor Eligibility Using Individual Risk-Based Questions to Reduce the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products. US Food and Drug Administration; 2023.
   Google Scholar
• Cho JE. National blood management system and the direction of government policy in Korea. Korean J Hematol. 2010;45(2):81. doi:10.5045/kjh.2010.45.2.81
   PubMedGoogle Scholar
• Kim HO. Current state of blood management services in Korea. Ann Lab Med. 2022;42(3):306–313. doi:10.3343/alm.2022.42.3.306
   PubMed Web of Science ®Google Scholar
• Checkley L, Motwani G, Wange IC, et al. Assessment of blood donation and transfusion in Eastern Uganda: a Mixed-Methods Study. Ann Glob Health. 2019;85(1). doi:10.5334/aogh.2426
   PubMed Web of Science ®Google Scholar
• Ministry of Health and Family Welfare. Drugs and Cosmetics Act, 1945. Final G.S.R. 166(E) _Amendment in Part X B & Part XII B pertains to Blood centre and Blood components. The Gazette of India: Extraordinary; 1945. Available from: https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/download_file_division.jsp?num_id=NTc2MQ. Accessed January 21, 2023.
   Google Scholar
• Gammon RR, Boyd T, Chanez T. Standards for Blood Banks and Transfusion Services. 33rd ed. Bethesda, MD: AABB; 2022.
   Google Scholar
• Roubinian NH, Plimier C, Woo JP, et al. Effect of donor, component, and recipient characteristics on hemoglobin increments following red blood cell transfusion. Blood J Am Soci Hematol. 2019;134(13):1003–1013.
   Google Scholar
• De Kort W, Mayr W, Jungbauer C, et al. Blood donor selection in European Union directives: room for improvement. Blood Transfus. 2016;14(2):101. doi:10.2450/2015.0148-15
   PubMed Web of Science ®Google Scholar
• Miller AS, Cahill S, Mayer KH. FDA’s 2023 Policy Update—Promoting Safety and Inclusivity in Blood Donation. JAMA Health Forum. 2023;4(8):e232388. doi:10.1001/jamahealthforum.2023.2388
   PubMedGoogle Scholar
• Blood Donor Eligibility Criteria. Red Cross blood services; 2023. Availabe from: https://www.redcrossblood.org/donate-blood/how-to-donate/eligibility-requirements/eligibility-criteria-alphabetical.html. Accessed March 19, 2023.
   Google Scholar
• Memon A, Doll SR. A search for unknown blood-borne oncogenic viruses. Int J Cancer. 1994;58(3):366–368. doi:10.1002/ijc.2910580310
   PubMed Web of Science ®Google Scholar
• Dzik WH, Okayama A. Can blood transfusion transmit disease-producing genes? Transfusion. 1999;39(8):795–800. doi:10.1046/j.1537-2995.1999.39080795.x
   PubMed Web of Science ®Google Scholar
• NACO, NBTC. Guidel. Blood Donor Sel; 2017. Availabe from: http://nbtc.naco.gov.in/page/publications/. Accessed March 19, 2023.
   Google Scholar
• Blood donor selection guideline on assessing donor suitability for blood donation; 2012. Available from: https://www.ncbi.nlm.nih.gov/books/NBK138219/. Accessed December 24, 2022.
   Google Scholar
• Government Publishing Office. 21 CFR 600-799. Code of Federal Regulations. Government Publishing Office; 2022.
   Google Scholar
• Dorsey KA, Moritz ED, Steele WR, Eder AF, Stramer SL. A comparison of human immunodeficiency virus, hepatitis C virus, hepatitis B virus, and human T-lymphotropic virus marker rates for directed versus volunteer blood donations to the American Red Cross during 2005 to 2010. Transfusion. 2013;53(6):1250–1256. doi:10.1111/j.1537-2995.2012.03904.x
   PubMed Web of Science ®Google Scholar
• Etchason J, Petz L, Keeler E, et al. The cost effectiveness of preoperative autologous blood donations. N Engl J Med. 1995;332(11):719–724. doi:10.1056/NEJM199503163321106
   PubMed Web of Science ®Google Scholar
• Domen RE. Preoperative autologous blood donation: clinical, economic, and ethical issues. Cleve Clin J Med. 1996;63(5):295–300. doi:10.3949/ccjm.63.5.295
   PubMed Web of Science ®Google Scholar
• Goodnough LT. Autologous Blood Donation. Anesthesiol Clin North Am. 2005;23(2):263–270. doi:10.1016/j.atc.2004.07.003
   PubMedGoogle Scholar
• Yomtovian R. Practical aspects of preoperative autologous transfusion. Am J Clin Pathol. 1997;107(4 Suppl 1):S28–35.
   PubMed Web of Science ®Google Scholar
• Domen R. Adverse reactions associated with autologous blood transfusion: evaluation and incidence at a large academic hospital. Transfusion. 1998;38(3):296–300. doi:10.1046/j.1537-2995.1998.38398222875.x
   PubMed Web of Science ®Google Scholar
• Letts M, Perng R, Luke B, Jarvis J, Lawton L, Hoey S. An analysis of a preoperative pediatric autologous blood donation program. Can J Surg. 2000;43(2):125–129.
   PubMed Web of Science ®Google Scholar
• Rock G, Berger R, Filion D, et al. Autologous blood programs: what is happening? Transfus Apher Sci. 2008;39(3):193–197. doi:10.1016/j.transci.2008.09.014
   PubMed Web of Science ®Google Scholar
• Axelrod F, Pepkowitz S, Goldfinger D. Establishment of a schedule of optimal preoperative collection of autologous blood. Transfusion. 1989;29(8):677–680. doi:10.1046/j.1537-2995.1989.29890020438.x
   PubMed Web of Science ®Google Scholar
• Birkmeyer JD, Goodnough LT, AuBuchon JP, Noordsij PG, Littenberg B. The cost-effectiveness of preoperative autologous blood donation for total Hip and knee replacement. Transfusion. 1993;33(7):544–551. doi:10.1046/j.1537-2995.1993.33793325048.x
   PubMed Web of Science ®Google Scholar
• Birkmeyer JD, AuBuchon JP, Littenberg B, et al. Cost-effectiveness of preoperative autologons donation in coronary artery bypass grafting. Ann Thorac Surg. 1994;57(1):161–168. doi:10.1016/0003-4975(94)90386-7
   PubMed Web of Science ®Google Scholar
• Stehling L, Zauder H. Controversies in transfusion medicine. Perioperative hemodilution: pro. Transfusion. 1994;34(3):265–268. doi:10.1046/j.1537-2995.1994.34394196628.x
   PubMed Web of Science ®Google Scholar
• Domen RE, Ribicki LA, Hoeltge GA. An analysis of autologous blood donor motivational factors. Vox Sang. 1995;69(2):110–113. doi:10.1111/j.1423-0410.1995.tb01679.x
   PubMed Web of Science ®Google Scholar
• Henry DA, Carless PA, Moxey AJ, O’Connell D, Ker K, Fergusson DA. Pre-operative autologous donation for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2001;2010(4). doi:10.1002/14651858.CD003602
   Google Scholar
• Henry DA, Moxey AJ, Carless PA, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. In: editor, Henry DA. Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd; 2001. doi:10.1002/14651858.CD001886.pub2
   Google Scholar
• World Health Organization. Towards 100% voluntary blood donation: a global framework for action; 2010. Available from: https://www.ncbi.nlm.nih.gov/books/NBK305666. Accessed January 21, 2023.
   Google Scholar
• National AIDS Control Organisation. Ministry of Health and Family Welfare. Government of India. Voluntary blood donation programme - an operational guideline; 2007.
   Google Scholar
• Ad-Drees A. Attitude, belief and knowledge about blood donation and transfusion in Saudi population. Pak J Med Sci. 2008;24(1):74–79.
   Web of Science ®Google Scholar
• Matee MI, Magesa PM, Lyamuya EF. Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis infections among blood donors at the Muhimbili National Hospital in Dar es Salaam, Tanzania. BMC Public Health. 2006;6(1):21. doi:10.1186/1471-2458-6-21
   PubMedGoogle Scholar
• Sharma RR, Cheema R, Vajpayee M, et al. Prevalence of markers of transfusion transmissible diseases in voluntary and replacement blood donors. Natl Med J India. 2004;17(1):19–21.
   PubMed Web of Science ®Google Scholar
• Sultan F, Mehmood T, Mahmood MT. Infectious pathogens in volunteer and replacement blood donors in Pakistan: a ten-year experience. Int J Infect Dis. 2007;11(5):407–412. doi:10.1016/j.ijid.2006.10.004
   PubMed Web of Science ®Google Scholar
• Mremi A, Yahaya JJ, Nyindo M, Mollel E. Transfusion-transmitted infections and associated risk factors at the Northern Zone Blood Transfusion Center in Tanzania: a study of blood donors between 2017 and 2019. PLoS One. 2021;16(3):e0249061. doi:10.1371/journal.pone.0249061
   PubMed Web of Science ®Google Scholar
• Twenty-Eighth World Health Assembly. WHA28.72-Utilization and Supply of Human Blood and Blood Products. Geneva: Twenty-Eighth World Health Assembly; 1975.
   Google Scholar
• Asenso-Mensah K, Achina G, Appiah R, Owusu-Ofori S, Allain JP. Can family or replacement blood donors become regular volunteer donors? Transfusion. 2014;54(3pt2):797–804. doi:10.1111/trf.12216
   PubMedGoogle Scholar
• Allain JP, Sarkodie F, Asenso-Mensah K, Owusu-Ofori S. Relative safety of first-time volunteer and replacement donors in West Africa. Transfusion. 2010;50(2):340–343. doi:10.1111/j.1537-2995.2009.02444.x
   PubMed Web of Science ®Google Scholar
• Loua A, Nze Nkoure G. Relative safety of first-time volunteer and replacement donors in Guinea. Transfusion. 2010;50(8):1850–1851; author reply 1851–2. doi:10.1111/j.1537-2995.2010.02718.x
   Web of Science ®Google Scholar
• Mbanya DN, Feunou F, Tayou TC. Volunteer or family/replacement donations: are the tides changing? Transfusion. 2010;50(8):1849–1850. doi:10.1111/j.1537-2995.2010.02656.x
   PubMed Web of Science ®Google Scholar
• Bates I, Hassall O. Should we neglect or nurture replacement blood donors in sub-Saharan Africa? Biologicals. 2010;38(1):65–67. doi:10.1016/j.biologicals.2009.10.013
   PubMed Web of Science ®Google Scholar
• Passweg JR, Baldomero H, Chabannon C, et al. The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T’s come into focus. Bone Marrow Transplant. 2020;55(8):1604–1613. doi:10.1038/s41409-020-0826-4
   PubMed Web of Science ®Google Scholar
• Greinacher A, Fendrich K, Hoffmann W. Demographic changes: the impact for safe blood supply. Transfus Med Hemother. 2010;37(3):141–148. doi:10.1159/000313949
   PubMed Web of Science ®Google Scholar
• Jones JM, Sapiano MRP, Savinkina AA, et al. Slowing decline in blood collection and transfusion in the United States - 2017. Transfusion. 2020;60(Suppl 2):S1–S9. doi:10.1111/trf.15604
   PubMedGoogle Scholar
• Rossmann SN, Townsend M, Simon TL. Recruitment and screening of donors and the collection of blood. Rossi’s Princ Transfus Med. 2022;2022:25–36.
   Google Scholar
• Vamvakas E, Taswell H. Epidemiology of blood transfusion. Transfusion. 1994;34(6):464–470. doi:10.1046/j.1537-2995.1994.34694295059.x
   PubMed Web of Science ®Google Scholar
• Zou S, Musavi F, Notari EP, Fang CT. Changing age distribution of the blood donor population in the United States. Transfusion. 2007;071117010348009. doi:10.1111/j.1537-2995.2007.01517.x
   Web of Science ®Google Scholar
• Currie CJ, Patel TC, McEwan P, Dixon S. Evaluation of the future supply and demand for blood products in the United Kingdom National Health Service. Transfus Med. 2004;14(1):19–24. doi:10.1111/j.0958-7578.2004.00475.x
   PubMed Web of Science ®Google Scholar
• Liu W, Chen Y, Hsu L, Chen J, Wei S, Hou S. An imbalance in blood collection and demand is anticipated to occur in the near future in Taiwan. J Formosan Med Assoc. 2022;21(8):1610–1614. doi:10.1016/j.jfma.2021.07.027
   Google Scholar
• Ali A, Auvinen MK, Rautonen J. Blood donors and Blood Collection: the aging population poses a global challenge for blood services. Transfusion. 2009;50(3):584–588. doi:10.1111/j.1537-2995.2009.02490.x
   PubMed Web of Science ®Google Scholar
• Ugwu A, Gwarzo D, Nwagha T, Gwarzo A, Greinacher A. Transfusion in limited infrastructure locations – where to go decades after safe blood initiative by World Health Organization? ISBT Sci Ser. 2020;15(1):118–125. doi:10.1111/voxs.12519
   Google Scholar
• Erhabor O, Adias T, Mainasara A. Provisions of safe blood transfusion services in low income setting in West Africa, case study of Nigeria. Adv Med Biol. 2013;59:1–58.
   Google Scholar
• Custer B, Zou S, Glynn SA, et al. Addressing gaps in international blood availability and transfusion safety in low-and middle-income countries: a NHLBI workshop. Transfusion. 2018;58(5):1307–1317. doi:10.1111/trf.14598
   PubMed Web of Science ®Google Scholar
• Sullivan HC, Roback JD. The pillars of patient blood management: key to successful implementation (Article, p. 2840). Transfusion. 2019;59(9):2763–2767. doi:10.1111/trf.15464
   PubMed Web of Science ®Google Scholar
• Leahy MF, Hofmann A, Towler S, et al. Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. Transfusion. 2017;57(6):1347–1358. doi:10.1111/trf.14006
   PubMed Web of Science ®Google Scholar
• Leahy MF, Trentino KM, May C, Swain SG, Chuah H, Farmer SL. Blood use in patients receiving intensive chemotherapy for acute leukemia or hematopoietic stem cell transplantation: the impact of a health system-wide patient blood management program. Transfusion. 2017;57(9):2189–2196. doi:10.1111/trf.14191
   PubMed Web of Science ®Google Scholar
• Heitmiller ES, Hill RB, Marshall CE, et al. Blood wastage reduction using Lean Sigma methodology. Transfusion. 2010;50(9):1887–1896. doi:10.1111/j.1537-2995.2010.02679.x
   PubMed Web of Science ®Google Scholar
• Levin JH, Collins L, Adekunle O, et al. Blood product wastage reduction by utilising low-cost, low-impact multimodal physician-to-physician communication initiatives. Transfus Med. 2019;29(6):389–393. doi:10.1111/tme.12640
   PubMed Web of Science ®Google Scholar
• Morgan TO. Blood conservation: the CEO perspective. J Cardiothorac Vasc Anesth. 2004;18(4):S15–S17. doi:10.1053/j.jvca.2004.06.003
   Web of Science ®Google Scholar
• McKinney M. Maine hospital slashes transfusions, reducing patient risk, costs. Mod Healthc. 2014;25:30.
   Google Scholar
• World Health Organization. The Urgent Need to Implement Patient Blood Management: Policy Brief. World Health Organization; 2021.
   Google Scholar
• Stanworth SJ, New HV, Apelseth TO, et al. Effects of the COVID-19 pandemic on supply and use of blood for transfusion. Lancet Haematol. 2020;7(10):e756–e764. doi:10.1016/S2352-3026(20)30186-1
   PubMed Web of Science ®Google Scholar
• Flegel WA. COVID‐19 insights from transfusion medicine. Br J Haematol. 2020;190(5):715–717. doi:10.1111/bjh.17005
   PubMed Web of Science ®Google Scholar
• Delabranche X, Kientz D, Tacquard C, et al. Impact of COVID‐19 and lockdown regarding blood transfusion. Transfusion. 2021;61(8):2327–2335. doi:10.1111/trf.16422
   PubMed Web of Science ®Google Scholar
• Fede J, Hinrichsen C. Improving red blood cell usage at an academic medical center. Medical Laboratory Observer; 2022.
   Google Scholar
• Jacobs JW, Karafin MS, Allen ES, et al. Blood conservation strategies at United States hospitals during the COVID ‐19 pandemic: findings from a multi‐institutional analysis ‐ International Society of Blood Transfusion survey. Transfusion. 2022;62(11):2271–2281. doi:10.1111/trf.17116
   PubMed Web of Science ®Google Scholar
• Kheirbeck T, Martin T, Wakely M, Lueckel S, Adams C. Safety and feasibility of ultra-restrictive transfusion protocol as a blood-preservation strategy during shortage crises. R I Med J. 2022;49–54. Available from: http://www.rimed.org/rimedicaljournal/2022/09/2022-09.pdf#page=49.
   Google Scholar
• Doughty H, Green L, Callum J, Murphy MF. Triage tool for the rationing of blood for massively bleeding patients during a severe national blood shortage: guidance from the National Blood Transfusion Committee. Br J Haematol. 2020;191(3):340–346. doi:10.1111/bjh.16736
   PubMed Web of Science ®Google Scholar
• Beverina I, Ranzini M. A synchronized approach between emergency department and anemia clinic to intravenous irontreatmentforverysevere(Hb<7.0g/dL) and extreme (<5.0 g/dL) iron-deficiency anemia: short-, medium- and long-term efficacy and safety analysis. Blood Transfus. 2023;21(3):235–239. doi:10.2450/2023.0199-22
   PubMed Web of Science ®Google Scholar
• Bolcato M, Russo M, Trentino K, Isbister J, Rodriguez D, Aprile A. Patient blood management: the best approach to transfusion medicine risk management. Transfus Apher Sci. 2020;59(4). doi:10.1016/j.transci.2020.102779
   Web of Science ®Google Scholar